ESS
37
-2
VFC
79
2
DLTR
66
4
BA
40
-2
NKE
42
2
STT
71
4
DHI
39
-2
ORCL
37
3
DGX
36
-3
HUM
35
2
NOV
55
-3
EXR
19
-3
ITW
39
2
ZBH
47
-9
PEP
41
-4
VZ
44
-11
ADI
78
-2
MCK
63
-3
AMGN
31
-5
ZION
61
-2
ESS
37
-2
VFC
79
2
DLTR
66
4
BA
40
-2
NKE
42
2
STT
71
4
DHI
39
-2
ORCL
37
3
DGX
36
-3
HUM
35
2
NOV
55
-3
EXR
19
-3
ITW
39
2
ZBH
47
-9
PEP
41
-4
VZ
44
-11
ADI
78
-2
MCK
63
-3
AMGN
31
-5
ZION
61
-2
Financhill
Back

Cardiol Therapeutics, Inc. 10K Form

Buy
55

CRDL
Cardiol Therapeutics, Inc.

Last Price:
$1.01
Seasonality Move:
14.38%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CRDL News And Ratings

See the #1 stock for the next 7 days that we like better than CRDL

CRDL Financial Statistics

Sales & Book Value

Annual Sales: $0
Cash Flow: $-5.1M
Price / Cash Flow: 0
Annual Sales: $0.08
Price / Book: 15.28

Profitability

EPS (TTM): -0.29980
Net Income (TTM): $-24.9M
Gross Margin: $-272.4K
Return on Equity: -236.38%
Return on Assets: -162.23%

Cardiol Therapeutics, Inc. Earnings Forecast

Key Cardiol Therapeutics, Inc. Financial Ratios

  • Per Share Earnings over the last 8 years have been positive in 3 years.

Cardiol Therapeutics, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: CRDL
Website: cardiolrx.com

Debt

Debt-to-Equity Ratio: 0.01
Current Ratio: 3.89
Quick Ratio: 3.54

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

CRDL Technical Analysis vs Fundamental Analysis

Buy
55
Cardiol Therapeutics, Inc. (CRDL) is a Buy

Is Cardiol Therapeutics, Inc. a Buy or a Sell?